{"id":"https://openalex.org/W4361896647","doi":"https://doi.org/10.1158/0008-5472.22411494","title":"Supplementary Tables S1-S4 from Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients","display_name":"Supplementary Tables S1-S4 from Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361896647","doi":"https://doi.org/10.1158/0008-5472.22411494"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22411494","doi":"https://doi.org/10.1158/0008-5472.22411494","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22411494","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Tables_S1-S4_from_Chromogranin_A_Is_Preferentially_Cleaved_into_Proangiogenic_Peptides_in_the_Bone_Marrow_of_Multiple_Myeloma_Patients/22411494/1/files/39857409.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Tables_S1-S4_from_Chromogranin_A_Is_Preferentially_Cleaved_into_Proangiogenic_Peptides_in_the_Bone_Marrow_of_Multiple_Myeloma_Patients/22411494/1/files/39857409.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110966845","display_name":"Mimma Bianco","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mimma Bianco","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040436989","display_name":"Anna Maria Gasparri","orcid":"https://orcid.org/0000-0002-1757-8699","observed_orcids":["https://orcid.org/0000-0002-1757-8699"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Maria Gasparri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Barbara Colombo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara Colombo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062787367","display_name":"Flavio Curnis","orcid":"https://orcid.org/0000-0002-7231-9569","observed_orcids":["https://orcid.org/0000-0002-7231-9569"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Flavio Curnis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087920510","display_name":"Stefania Girlanda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefania Girlanda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016760892","display_name":"Maurilio Ponzoni","orcid":"https://orcid.org/0000-0002-0055-325X","observed_orcids":["https://orcid.org/0000-0002-0055-325X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maurilio Ponzoni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091685834","display_name":"Maria Teresa Sabrina Bertilaccio","orcid":"https://orcid.org/0000-0002-2304-4618","observed_orcids":["https://orcid.org/0000-0002-2304-4618"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Teresa Sabrina Bertilaccio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079690904","display_name":"Arianna Calcinotto","orcid":"https://orcid.org/0000-0003-1746-6424","observed_orcids":["https://orcid.org/0000-0003-1746-6424"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arianna Calcinotto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047480096","display_name":"Angelina Sacchi","orcid":"https://orcid.org/0000-0002-6594-0277","observed_orcids":["https://orcid.org/0000-0002-6594-0277"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angelina Sacchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060214201","display_name":"Elisabetta Ferrero","orcid":"https://orcid.org/0000-0003-2571-933X","observed_orcids":["https://orcid.org/0000-0003-2571-933X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elisabetta Ferrero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020048731","display_name":"Marina Ferrarini","orcid":"https://orcid.org/0000-0003-1015-9632","observed_orcids":["https://orcid.org/0000-0003-1015-9632"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina Ferrarini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007028620","display_name":"Marta Chesi","orcid":"https://orcid.org/0000-0002-4024-8225","observed_orcids":["https://orcid.org/0000-0002-4024-8225"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marta Chesi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004436275","display_name":"Peter Leif Bergsagel","orcid":"https://orcid.org/0000-0003-1523-7388","observed_orcids":["https://orcid.org/0000-0003-1523-7388"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Leif Bergsagel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020944852","display_name":"Matteo Bellone","orcid":"https://orcid.org/0000-0002-2586-2569","observed_orcids":["https://orcid.org/0000-0002-2586-2569"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matteo Bellone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050323670","display_name":"Giovanni Tonon","orcid":"https://orcid.org/0000-0003-2973-5038","observed_orcids":["https://orcid.org/0000-0003-2973-5038"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giovanni Tonon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026667594","display_name":"Fabio Ciceri","orcid":"https://orcid.org/0000-0003-0873-0123","observed_orcids":["https://orcid.org/0000-0003-0873-0123"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabio Ciceri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076929140","display_name":"Magda Marcatti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Magda Marcatti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090199263","display_name":"Federico Caligaris\u2010Cappio","orcid":"https://orcid.org/0000-0001-8674-1245","observed_orcids":["https://orcid.org/0000-0001-8674-1245"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Federico Caligaris-Cappio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5057238914","display_name":"Angelo Corti","orcid":"https://orcid.org/0000-0002-0893-6191","observed_orcids":["https://orcid.org/0000-0002-0893-6191"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angelo Corti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chromogranin-a","display_name":"chromogranin A","score":1.0},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/bone-marrow-plasma","display_name":"bone marrow plasma","score":0.8429999947547913},{"id":"https://openalex.org/keywords/fgf2","display_name":"FGF2","score":0.9139999747276306},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":1.0},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.7149999737739563},{"id":"https://openalex.org/keywords/clinical-factors","display_name":"clinical factors","score":0.3240000009536743}],"concepts":[{"id":"https://openalex.org/C77231918","wikidata":"https://www.wikidata.org/wiki/Q3698322","display_name":"Chromogranin A","level":3,"score":0.9180722832679749},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7793687582015991},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.6514854431152344},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.47314560413360596},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46049976348876953},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45826584100723267},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.41084861755371094},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3536154329776764},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.32956409454345703},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.06239524483680725},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.22411494","doi":"https://doi.org/10.1158/0008-5472.22411494","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22411494","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Tables_S1-S4_from_Chromogranin_A_Is_Preferentially_Cleaved_into_Proangiogenic_Peptides_in_the_Bone_Marrow_of_Multiple_Myeloma_Patients/22411494/1/files/39857409.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.22411494.v1","doi":"https://doi.org/10.1158/0008-5472.22411494.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22411494.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22411494","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Tables_S1-S4_from_Chromogranin_A_Is_Preferentially_Cleaved_into_Proangiogenic_Peptides_in_the_Bone_Marrow_of_Multiple_Myeloma_Patients/22411494","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22411494","doi":"https://doi.org/10.1158/0008-5472.22411494","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22411494","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Tables_S1-S4_from_Chromogranin_A_Is_Preferentially_Cleaved_into_Proangiogenic_Peptides_in_the_Bone_Marrow_of_Multiple_Myeloma_Patients/22411494/1/files/39857409.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361896647.pdf","grobid_xml":"https://content.openalex.org/works/W4361896647.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392680313","https://openalex.org/W2261866881","https://openalex.org/W2159679541","https://openalex.org/W2911654759","https://openalex.org/W7100062779","https://openalex.org/W2160618879","https://openalex.org/W2094019723","https://openalex.org/W2589782068","https://openalex.org/W2050440942","https://openalex.org/W2597361420"],"abstract_inverted_index":{"Demographic":[0],"and":[1,16,33,51],"clinical":[2,34],"data":[3],"regarding":[4],"the":[5,12],"study":[6],"population":[7],"(S1);":[8],"ELISAs":[9],"used":[10],"for":[11],"characterization":[13],"of":[14,29,47],"CgA":[15,31,49],"its":[17],"fragments":[18],"in":[19,36,55],"MM":[20,37,56],"plasma":[21,27,45],"samples":[22],"(S2);":[23],"Correlation":[24,42],"between":[25,43],"BM":[26,44],"levels":[28,46],"different":[30,48],"analytes":[32,50],"variables":[35],"patients":[38,57],"at":[39,58],"diagnosis":[40,59],"(S3);":[41],"FGF2":[52],"or":[53],"VEGF":[54],"(S4).":[60]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}